Belgium· BE-AMP-SAM032024-00
Sandomigran 0,5 mg
A pizotifen product containing pizotifen hydrogenomalate, registered in Belgium by Novartis Pharma. The same ATC class is registered in 7 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Pizotifen is registered in 7 of 19 countries.
Countries holding a registration under ATC N02CX01 (pizotifen), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 3 of them publish a price we can compare per daily dose
Pizotifen · ATC N02CX01
7 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Pizotifen Hydrogenomalate
- Manufacturer
- Novartis Pharma
- Country
- Belgium (BE)
- ATC code
- N02CX01
- ATC class
- Pizotifen
- Defined daily dose
- 1.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb0079681
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pizotifen in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceSANMIGRAN 0,50 mg, comprimé enrobéPHOENIX LABS (IRLANDE)
- IrelandSanomigran 500 microgram TabletsPhoenix Labs
- NetherlandsSandomigran 0,5 mg, omhulde tabletten 0,5 mgPhoenix Labs
- United KingdomPizotifen 1.5mg tabletsA A H Pharmaceuticals Ltd
- SpainMOSEGOR 0,5 mg/10 ml SOLUCION ORALEthyx Pharmaceuticals
- CanadaSANDOMIGRAN DSENDO OPERATIONS LTD.
- NorwaySandomigrinEthyx Pharmaceuticals SAS
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Cyprus · Pizogran
- Spain · Mosegor
- United Kingdom (Northern Ireland) · Pizotifen Tillomed Laboratories
- Ireland · Sanomigran
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/329c5106-fe56-495b-838a-f8ff29a54435 GET /v1/drugs/329c5106-fe56-495b-838a-f8ff29a54435?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Coated tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Sandomigran 0,5 mg",
"name_fr": "Sandomigran 0,5 mg",
"name_nl": "Sandomigran 0,5 mg",
"amp_code": "SAM032024-00",
"strengths": [
"0.7300",
"0.5000"
],
"pack_count": 1,
"substances": [
"Pizotifen Hydrogenomalate",
"Pizotifen"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Pizotifen",
"authorisation_numbers": [
"BE032024"
]
}See everything about pizotifen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.